Methylene-bridge tryptophan fatty acylation regulates PI3K-AKT signaling and glucose uptake

Song-Hua Hu,Xia-Di He,Ji Nie,Jun-Li Hou,Jiang Wu,Xiao-Yan Liu,Yun Wei,Hui-Ru Tang,Wen-Xing Sun,Shu-Xian Zhou,Yi-Yuan Yuan,Yan-Peng An,Guo-Quan Yan,Yan Lin,Peng-Cheng Lin,Jean J Zhao,Ming-Liang Ye,Jian-Yuan Zhao,Wei Xu,Shi-Min Zhao,Jean J. Zhao
DOI: https://doi.org/10.1016/j.celrep.2022.110509
IF: 8.8
2022-03-01
Cell Reports
Abstract:Protein fatty acylation regulates numerous cell signaling pathways. Polyunsaturated fatty acids (PUFAs) exert a plethora of physiological effects, including cell signaling regulation, with underlying mechanisms to be fully understood. Herein, we report that docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) regulate PI3K-AKT signaling by modifying PDK1 and AKT2. DHA-administered mice exhibit altered phosphorylation of proteins in signaling pathways. Methylene bridge-containing DHA/EPA acylate δ1 carbon of tryptophan 448/543 in PDK1 and tryptophan 414 in AKT2 via free radical pathway, recruit both the proteins to the cytoplasmic membrane, and activate PI3K signaling and glucose uptake in a tryptophan acylation-dependent but insulin-independent manner in cultured cells and in mice. DHA/EPA deplete cytosolic PDK1 and AKT2 and induce insulin resistance. Akt2 knockout in mice abrogates DHA/EPA-induced PI3K-AKT signaling. Our results identify PUFA's methylene bridge tryptophan acylation, a protein fatty acylation that regulates cell signaling and may underlie multifaceted effects of methylene-bridge-containing PUFAs.
cell biology
What problem does this paper attempt to address?